NDC 63323-286-01 - NAROPIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-286
- Requested NDC
- 63323-286-01
- Package NDCs from labels
- 63323-286-51, 63323-286-55, 63323-286-41, 63323-286-27, 63323-286-43, 63323-286-38, 63323-286-01, 63323-286-20, 63323-286-05, 63323-286-23, 63323-286-09, 63323-286-31, 63323-286-11, 63323-286-35, 63323-286-03, 63323-286-00, 63323-286-33, 63323-286-63, 63323-286-30, 63323-286-93, 63323-286-95
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2026-07-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NAROPIN - Henry Schein, Inc. | Henry Schein, Inc. | 2026-07-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Naropin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2026-07-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Naropin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-08-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Naropin - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | HP Halden Pharma AS | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | HP Halden Pharma AS | 2024-08-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Naropin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-07-10 | HUMAN PRESCRIPTION DRUG LABEL |
| NAROPIN - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-29 | HUMAN PRESCRIPTION DRUG LABEL |
| Naropin - APP Pharmaceuticals, LLC | Fresenius Kabi Norge AS | APP Pharmaceuticals, LLC | Fresenius Kabi Norge AS | 2011-09-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-286-00 | Naropin | 12 in 1 CASE | INJECTION, SOLUTION | 12 | 27 | |
| 63323-286-01 | Naropin | 20 mL in 1 AMPULE | INJECTION, SOLUTION | 20 | 27 | |
| 63323-286-03 | Naropin | 100 mL in 1 BOTTLE | INJECTION, SOLUTION | 100 | 27 | |
| 63323-286-05 | Naropin | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 27 | |
| 63323-286-09 | Naropin | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 27 | |
| 63323-286-11 | Naropin | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 27 | |
| 63323-286-20 | Naropin | 5 in 1 BOX | INJECTION, SOLUTION | 5 | 27 | |
| 63323-286-23 | Naropin | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 27 | |
| 63323-286-30 | Naropin | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 27 | |
| 63323-286-30 | Naropin | 1 in 1 BOX | INJECTION, SOLUTION | 1 | 27 | |
| 63323-286-31 | Naropin | 5 in 1 BOX | INJECTION, SOLUTION | 5 | 27 | |
| 63323-286-33 | Naropin | 200 mL in 1 BOTTLE | INJECTION, SOLUTION | 200 | 27 | |
| 63323-286-35 | Naropin | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 27 | |
| 63323-286-63 | Naropin | 12 in 1 CASE | INJECTION, SOLUTION | 12 | 27 | |
| 63323-286-93 | Naropin | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 8 | |
| 63323-286-95 | Naropin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 8 | |
| 63323-286-27 | Naropin | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 6 | |
| 63323-286-38 | Naropin | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 6 | |
| 63323-286-41 | Naropin | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 6 | |
| 63323-286-43 | Naropin | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-286 | NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 27 | Current NDC, Legacy NDC, 14 package rows | 20240814_23d2d448-a744-4877-9f2d-7e57c198da89.zip |
| 63323-286 | NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 8 | Current NDC, Legacy NDC, 2 package rows | 20240817_c6613708-c1f7-4f5c-91a3-ebbc1d7905c6.zip |
| 63323-286 | NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 6 | Current NDC, Legacy NDC, 4 package rows | 20240829_dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7.zip |
DailyMed Billing Units#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BM BIO27 | CALC PHOS, KALI PHOS, NAT MUR | BM Private Limited | 4d229815-05f4-27c5-e063-6394a90ac865 | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO1 | CALC PHOS, FERR PHOS, KALI PHOS, NAT MUR | BM Private Limited | 4d265d99-fdbb-5efb-e063-6394a90a89ac | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO16 | CALC PHOS, FERR PHOS, KALI PHOS, MAG PHOS, NAT MUR. | BM Private Limited | 4d26b4a9-ee27-6915-e063-6294a90a5d4d | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO12 | FERR PHOS, KALI PHOS, MAG PHOS, NAT MUR. | BM Private Limited | 4d2747ad-958e-63a1-e063-6294a90aea66 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Venture Healthcare Ltd | 31b812c9-fb0a-5ee0-e063-6294a90a03e1 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Venture Healthcare Ltd | 31b88e7c-eca0-5540-e063-6294a90a1b18 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Venture Healthcare Ltd | 31b8c3f4-e528-c69d-e063-6294a90a5a34 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Laboratoire Unither | 31b7eb13-39c3-6f0e-e063-6394a90a4011 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Laboratoire Unither | 31b8bb9c-d30f-152f-e063-6394a90a5208 | 2026-03-16 | Warnings | 451W47IQ8X |
| RESP EASE | SODIUM CHLORIDE | Laboratoire Unither | 31b8dcbd-9e6b-1edc-e063-6394a90aac73 | 2026-03-16 | Warnings | 451W47IQ8X |
| BM BIO20 | CALC FLUOR, CALC SULF, KALI SULF, NAT MUR, NAT SULF | BM Private Limited | 4d285396-9df8-86bc-e063-6294a90ad4de | 2026-03-16 | Warnings | 451W47IQ8X |
| HZ HP | LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NITRICUM ACIDUM, RANUNCULUS BULBOSUS, RHUS TOX, SEPIA, THUJA OCCIDENTALIS | BioActive Nutritional, Inc. | b662dea8-4eb5-4c80-a5ab-7d3688732773 | 2026-03-13 | Warnings | 451W47IQ8X |
| Drop20 | FUCUS VESICULOSUS, CHELIDONIUM MAJUS, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, QUERCUS GLANDIUM SPIRITUS, QUERCUS ROBUR, NUX VOMICA, PHYTOLACCA DECANDRA, ORNITHOGALUM UMBELLATUM, AGNUS CASTUS, BERBERIS AQUIFOLIUM, BERBERIS VULGARIS, SACCHARUM OFFICINALE, SOLIDAGO VIRGAUREA, CALCAREA CARBONICA, CARBO VEGETABILIS, MAGNESIA PHOSPHORICA, NATRUM PHOSPHORICUM, SINAPIS ARVENSIS, FLOS, UBIDECARENONUM, GRAPHITES, HYPOPHYSIS SUIS, PLACENTA TOTALIS SUIS, HYPOTHALAMUS (BOVINE) | Pick Enterprises Corp | baa96813-dc95-472e-a834-880a0cd484a7 | 2026-03-13 | Warnings | 451W47IQ8X |
| ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | Mylan Institutional LLC | 9e1d1b15-c224-4ff4-a39d-3b9cebfc8403 | 2026-03-13 | Warnings, Adverse reactions | 1734355 1734347 V910P86109 |
| Appetrol 20 | FUCUS VESICULOSUS, CHELIDONIUM MAJUS, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, QUERCUS GLANDIUM SPIRITUS, QUERCUS ROBUR, NUX VOMICA, PHYTOLACCA DECANDRA, ORNITHOGALUM UMBELLATUM, AGNUS CASTUS, BERBERIS AQUIFOLIUM, BERBERIS VULGARIS, SACCHARUM OFFICINALE, SOLIDAGO VIRGAUREA, CALCAREA CARBONICA, CARBO VEGETABILIS, MAGNESIA PHOSPHORICA, NATRUM PHOSPHORICUM, SINAPIS ARVENSIS, FLOS, UBIDECARENONUM, GRAPHITES, HYPOPHYSIS SUIS, PLACENTA TOTALIS SUIS, HYPOTHALAMUS (BOVINE) | Carbalor LLC | d66234a3-2477-42be-8f7b-283e3a5f87ed | 2026-03-12 | Warnings | 451W47IQ8X |
| Skin Irritations and Itch Relief | AGARICUS MUSCARIUS, ALUMINA, ANAGALLIS ARVENSIS, ANTIMONIUM TARTARICUM, APIS MELLIFICA, ARSENICUM ALBUM, ARSENICUM IODATUM, BOVISTA, CAUSTICUM, DOLICHOS PRURIENS, FAGOPYRUM ESCULENTUM, GRAPHITES, KALI MURIATICUM, MURIATICUM ACIDUM, OLEANDER, PETROLEUM, PIX LIQUIDA, RADIUM BROMATUM (12X, 30X, 1LM), RHUS TOX, SELENIUM METALLICUM, SULPHUR AND URTICA URENS. | King Bio Inc. | d139d2f1-0369-4963-9f3d-c4cc0f1ea2dd | 2026-03-10 | Warnings | QTT17582CB |
| Constitutional Enhancer | ACONITUM NAPELLUS, ARSENICUM ALBUM, BARYTA CARBONICA, BRYONIA, CALCAREA CARBONICA, CANTHARIS, GELSEMIUM SEMPERVIRENS, GRAPHITES, HYDRASTIS CANADENSIS, KALI IODATUM, LACHESIS MUTUS, LYCOPODIUM CLAVATUM, MERCURIUS VIVUS, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS, PHYTOLACCA DECANDRA, PULSATILLA, RHUS TOX, SEPIA, SILICEA AND SULPHUR. | King Bio Inc. | 448becd7-58aa-40ae-9b4b-39f48a8f13dd | 2026-03-10 | Warnings | 451W47IQ8X |
| ROPIVACAINE HYDROCHLORIDE | ROPIVACAINE HYDROCHLORIDE | Glenmark Pharmaceuticals Inc., USA | 043b28cc-ce5c-4351-a646-704c381decb9 | 2026-03-09 | Warnings, Adverse reactions | 1734203 1734483 1734207 1734475 1734084 V910P86109 |
| Sodium Chloride | SODIUM CHLORIDE | Hospira, Inc. | 018a8807-1331-41c3-4889-c7ec502a9043 | 2026-03-09 | Warnings, Adverse reactions | 451W47IQ8X |
| Headache and Migraine Relief | BELLADONNA, BRYONIA, CAPSICUM ANNUUM, GELSEMIUM, GLONOINUM, IGNATIA AMARA, KALI BICHROMICUM, KALI CARBONICUM, LYCOPODIUM, NATRUM MURIATICUM, NICCOLUM METALLICUM, NUX VOMICA, SANGUINARIA, SECALE CORNUTUM, SPIGELIA ANTH AND SULPHUR. | King Bio Inc. | efbfd58c-f3a6-4734-a37f-9f58fded990a | 2026-03-06 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.